{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-25-000132","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2025-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.915767+00:00","generated_at":"2026-05-17T09:29:24.059441+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immunovant shareholders elect all three director nominees, ratify auditor, approve say-on-pay","bullets":["Jacob Bauer, Douglas Hughes, and Robert Susman elected to Board until 2026 annual meeting.","Ernst & Young ratified as independent auditor for FY ending March 31, 2026 (165.4M for, 7K against).","Non-binding advisory vote on named executive officer compensation approved (159.0M for, 1.2M against).","Approximately 97% of outstanding shares represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-25-000132","json":"https://secwatch.observer/filing/0001764013-25-000132.json","markdown":"https://secwatch.observer/filing/0001764013-25-000132.md","text":"https://secwatch.observer/filing/0001764013-25-000132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000132/0001764013-25-000132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000132/imvt-20250827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:29:24.059441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}